Day One Biopharmaceuticals, Inc. (DAWN)

Apr 21, 2026 - DAWN was delisted (reason: acquired by Servier)

21.53

+0.04 (0.19%)

Inactive · Last trade price on Apr 22, 2026

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Identification, Development and Commercialization of Medicines	158.18M	131.16M	-	-	-
Identification, Development and Commercialization of Medicines Growth	20.60%	-	-	-	-
Total	158.18M	131.16M	-	-	-
Total Growth	20.60%	-	-	-	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
United States	158.18M	131.16M	-	-	-
United States Growth	20.60%	-	-	-	-
Total	158.18M	131.16M	-	-	-
Total Growth	20.60%	-	-	-	-

Source: S&P Global Market Intelligence.